428 related articles for article (PubMed ID: 25225281)
1. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
J Rheumatol; 2014 Oct; 41(10):1998-2007. PubMed ID: 25225281
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis.
Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
J Rheumatol; 2015 Aug; 42(8):1392-400. PubMed ID: 26077406
[TBL] [Abstract][Full Text] [Related]
3. Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.
Singh JA; Hossain A; Kotb A; Oliveira A; Mudano AS; Grossman J; Winthrop K; Wells GA
J Rheumatol; 2016 Oct; 43(10):1801-1815. PubMed ID: 27585688
[TBL] [Abstract][Full Text] [Related]
4. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment for proliferative lupus nephritis.
Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
[TBL] [Abstract][Full Text] [Related]
6. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Mok CC
Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
8. Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.
Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
Lupus; 2010 May; 19(6):703-10. PubMed ID: 20064907
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Z Rheumatol; 2017 Dec; 76(10):904-912. PubMed ID: 27638015
[TBL] [Abstract][Full Text] [Related]
10. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis.
Singh JA; Hossain A; Kotb A; Wells GA
Syst Rev; 2016 Sep; 5(1):155. PubMed ID: 27619512
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
[TBL] [Abstract][Full Text] [Related]
13. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
Contreras G; Tozman E; Nahar N; Metz D
Lupus; 2005; 14 Suppl 1():s33-8. PubMed ID: 15803929
[TBL] [Abstract][Full Text] [Related]
14. Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis.
Lee YH; Song GG
Pharmacology; 2022; 107(9-10):439-445. PubMed ID: 35609529
[TBL] [Abstract][Full Text] [Related]
15. Con: Cyclophosphamide for the treatment of lupus nephritis.
Mok CC
Nephrol Dial Transplant; 2016 Jul; 31(7):1053-7. PubMed ID: 27190358
[TBL] [Abstract][Full Text] [Related]
16. The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.
Baskin E; Ozen S; Cakar N; Bayrakci US; Demirkaya E; Bakkaloglu A
Pediatr Nephrol; 2010 Jan; 25(1):111-7. PubMed ID: 19727839
[TBL] [Abstract][Full Text] [Related]
17. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
Sedhain A; Hada R; Agrawal RK; Bhattarai GR; Baral A
BMC Nephrol; 2018 Jul; 19(1):175. PubMed ID: 29996800
[TBL] [Abstract][Full Text] [Related]
18. What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?
Jones RB; Walsh M; Smith KG
Curr Opin Rheumatol; 2009 May; 21(3):256-61. PubMed ID: 19399995
[TBL] [Abstract][Full Text] [Related]
19. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
Almalki AH; Alrowaie FA; Alhozali HM; Almalki NK; Alsubei AI; Alturki MS; Sadagah LF
Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.
Kamanamool N; McEvoy M; Attia J; Ingsathit A; Ngamjanyaporn P; Thakkinstian A
Medicine (Baltimore); 2010 Jul; 89(4):227-235. PubMed ID: 20616662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
